New York Post
@nypost·2.4M subscribers·43.2K videos
Trump Fast Tracks Psychedelic Drug Research
Posted
April 18, 2026
Views
13,378
Likes
558
Comments
368
Engagement
6.92%
April 18, 2026
13,378
558
368
6.92%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
2:49Now PlayingPresident Trump on Saturday signed an executive order to expedite research into the psychedelic ibogaine – a drug championed by podcaster Joe Rogan – so it can be used to treat PTSD in veterans and traumatic brain injuries. The drug is currently classified as a Schedule I controlled substance in the United States. The order will remove legal restrictions that have prevented extensive studies into the medicine and how it works.
#shroomtrip #psychedelicscience #trump #ptsd
The New York Post is your source for breaking news, news about New York, sports, business, entertainment, opinion, real estate, culture, fashion, and more.
Check out our three new podcasts:
NYNext (week)
Pod Force One with MIranda Devine (weekly)
NY POSTcast (daily)
Get The Post’s latest headlines everyday with our Morning Report newsletter:
Catch the latest news at
Follow The New York Post on:
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
